Please login to the form below
Phagenesis
This page shows the latest Phagenesis news and features for those working in and with pharma, biotech and healthcare.
Nestlé Health Science invests $145m in food allergy biotech
These include Nestlé's $1.9bn partnership on potential inflammatory bowel disease treatments and the acquisition of UK medical device firm and dysphagia specialist Phagenesis..
Latest news
-
Nestlé Health Science buys medical device firm
Acquisition of UK's Phagenesis expected to be completed by 2019. Nestlé Health Science is continuing to expand its interests in the broader pharma space with the acquisition of UK medical ... The staged acquisition is expected to close in 2019 but
More from news
Approximately 1 fully matching, plus 1 partially matching documents found.
Featured jobs
- FREELANCE Medical Writer (Initial 2/ 3 months term) - London Off...
-
Excellent Daily Rate
- Account Director, Healthcare Communications
-
Salary TBC
-
Account Director – UK Office
-
Excellent salary and benefits
- Senior Medical Writer, Healthcare Advertising Agency
-
£45, 000 – £50, 000
- Account Director - Medical Communications - London / South East
-
Excellent Salary and Benefits on offer
- Senior Account Executive – Account Manager – Healthcare Advertis...
-
£32000 - £43000 Bonus Benfits
- FREELANCE Account Director – Healthcare Advertising – London – 3...
-
Competitive Daily Rates
- Account Director – London based Medical Communications Agency
-
Excellent Remuneration Package
Subscribe to our email news alerts
- GSK hires Merck KGaA exec to lead US pharma business
- Novartis chooses internal replacement for US pharma president role
- AZ, Merck’s Lynparza scores market-expanding clinical success
- Senators attack Novartis over 'unconscionable' handling of Zolgensma data
- Boris Johnson announces fast-track immigration plans for top scientists
- Lilly psoriasis drug beats J&J's Tremfya in head-to-head trial
- Blended Intelligence
- Planning a pharma exhibition stand? You must read this!
- Leaked no-deal Brexit document forecasts widespread shortages
- AbbVie scores FDA approval for arthritis treatment upadacitinib
- Novo Nordisk shareholder revolt reaches Europe
- BMS buoyed by FDA approval of Celgene’s myelofibrosis drug
PMHub
Fishawack Group of Companies
The Fishawack Group of Companies is one of the largest independent medical communications and medical marketing specialists, with teams in...
Latest intelligence
- Blended Intelligence
- Data is the most valued commodity of the modern world. For P&P it's all about the application....
- The relevance of patient perspectives to value
- Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
- How is the NHS Long-term Plan being put into action?
- Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...
Quick links
Infographics
